Actively Recruiting
Home-Based Leg Dexterity Trainer for Management of Knee Osteoarthritis
Led by Steadman Philippon Research Institute · Updated on 2026-02-09
82
Participants Needed
1
Research Sites
120 weeks
Total Duration
On this page
Sponsors
S
Steadman Philippon Research Institute
Lead Sponsor
N
Neuromuscular Dynamics
Collaborating Sponsor
AI-Summary
What this Trial Is About
Rationale: Roughly 14 million adults aged 60 or older (10% male/13% female) in the United States experience symptoms of knee osteoarthritis (OA). Knee OA pain progressively impacts aging, reducing mobility and increasing morbidity. Nonsurgical self-management of knee OA includes exercise to promote proper knee mechanics, non-steroidal anti-inflammatory drugs (NSAIDs), cortisone injections, and weight loss to reduce pain and retain function. As OA has no cure, self-management progresses to \~1 million joint replacements per year. Critically, home-based devices are lacking for specifically training the low-level proprioceptive and neuromuscular circuitry for proper knee mechanics in a safe, focused, mechanistic way. Such devices would supplement exercises for strength, mobility, and whole-body loading and movement. Initially considered a wear-and-tear condition, knee OA is now understood as a complex disease involving inflammatory responses to mechanical loading and neuromuscular feedback loops among pain, joint damage, and dynamic loading. Home-based exercises remain a primary nonpharmacological and nonsurgical approach to managing chronic pain in OA that fundamentally disrupts proprioception and neuromuscular control of the joint, which accelerates articular degeneration. Neuromuscular Dynamics, LLC has developed a simple, safe, quick, and effective Leg Dexterity System that is portable, wireless, and coupled to HIPAA-compliant cloud analytics. A seated participant uses their foot to compress a platform atop a slender spring, which becomes unstable as it begins to buckle at low forces. The participant must then control their leg dexterity (i.e., via short-latency sensorimotor circuits) to stabilize the unstable dynamic foot-ground interactions. A tablet computer connected to the device provides feedback during use and uploads the participant's activity data to the server for analysis and reporting, accessible to users and clinicians. The investigators have successfully tested Leg Dexterity in control participants in multiple publications. The Leg Dexterity test is safe and poses minimal risk as the forces needed to do it are very low, does not involve full weight- bearing maneuvers, and is performed while seated without the risk of falling. Study: The investigators will conduct a randomized home-based clinical trial in knee OA to demonstrate the efficacy of leg dexterity training to reduce pain and improve function compared to currently prescribed dynamic exercise on a wobble board (a commonly used approach for improving proprioception and balance). Successful completion of this study will justify the adoption of the Leg Dexterity System as an effective at-home supplement to any nonsurgical management of knee OA. The investigators propose a longitudinal double-blind dose-matched trial comparing 8 weeks of leg dexterity training (Treatment using a slender, unstable spring system that engages short-latency sensorimotor control, 42 participants) vs. at-home wobble board exercises (Control, 42 participants) at the Steadman Philippon Research Institute.
CONDITIONS
Official Title
Home-Based Leg Dexterity Trainer for Management of Knee Osteoarthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 40 to 85 years
- Able to walk and move around at home and in the community
- History of knee osteoarthritis in one or both knees (Kellgren-Lawrence grade II-IV)
- Baseline knee pain of 3 to 10 points on the more-affected knee with at least 2 points difference compared to the other knee
- Able to personally provide informed consent and willing to follow all study procedures
You will not qualify if you...
- Planned surgery on either knee during the study period
- Knee arthroscopy or surgery within 6 months before consent
- Intra-articular steroid or hyaluronic acid treatment within 12 weeks before consent
- Planned steroid or hyaluronic acid treatment during the study period
- History of total or partial knee replacement on the target knee
- Blood disorders or active malignancy within 2 years before consent (except treated basal or squamous cell carcinoma)
- Diagnosis of fibromyalgia based on American College of Rheumatology criteria
- Known or suspected systemic autoimmune diseases or inflammatory arthritis
- History of other joint diseases such as gout, osteonecrosis, Paget's disease, Ehlers-Danlos Syndrome, or neuropathic arthropathy
- Any medical condition that poses risk or interferes with study participation
- Opioid use within 8 weeks before consent without willingness to discontinue during the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Steadman Philippon Research Institute
Vail, Colorado, United States, 81657
Actively Recruiting
Research Team
S
Sara Robinson, MS
CONTACT
S
Scott Tashman, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here